Literature DB >> 9547130

Response characteristics to antidepressants and placebo in post-traumatic stress disorder.

J R Davidson1, M L Malik, S N Sutherland.   

Abstract

Characteristic response patterns are described for two antidepressant drugs and placebo in post-traumatic stress disorder. Early onset and steady improvement occurred on a global rating scale for both drugs and placebo in those who ultimately met responder criteria at the end of treatment. In certain cases, the magnitude of global response was greater for drug than for placebo. At weeks 2 or 4, the Clinical Global Impressions score for fluoxetine but not for amitriptyline, served as a good predictor of eventual response. In a review of numerous completed placebo-controlled trials, antidepressants were superior to placebo in seven out of eight comparisons using the Clinical Global Impressions, although specific effects on post-traumatic stress disorder scales were more variable. Drug response rates are similar for combat and civilian trauma samples, but placebo response rates may be higher in the latter. Effect sizes suggested a moderate-to-good effect for drug therapy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9547130     DOI: 10.1097/00004850-199711000-00001

Source DB:  PubMed          Journal:  Int Clin Psychopharmacol        ISSN: 0268-1315            Impact factor:   1.659


  6 in total

Review 1.  Pharmacotherapy for post traumatic stress disorder (PTSD).

Authors:  Taryn Williams; Nicole J Phillips; Dan J Stein; Jonathan C Ipser
Journal:  Cochrane Database Syst Rev       Date:  2022-03-02

2.  A Proposed Algorithm for Improved Recognition and Treatment of the Depression/Anxiety Spectrum in Primary Care.

Authors:  James C. Ballenger; Jonathan R. T. Davidson; Yves Lecrubier; David J. Nutt
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2001-04

3.  Psychopharmacotherapy of posttraumatic stress disorder.

Authors:  Dragica Kozaric-Kovacic
Journal:  Croat Med J       Date:  2008-08       Impact factor: 1.351

Review 4.  Pharmacotherapy for post traumatic stress disorder (PTSD).

Authors:  D J Stein; J C Ipser; S Seedat
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

5.  Post-traumatic stress disorder: evidence-based research for the third millennium.

Authors:  Javier Iribarren; Paolo Prolo; Negoita Neagos; Francesco Chiappelli
Journal:  Evid Based Complement Alternat Med       Date:  2005-12       Impact factor: 2.629

Review 6.  Neurophysiology and Psychopathology Underlying PTSD and Recent Insights into the PTSD Therapies-A Comprehensive Review.

Authors:  Gjumrakch Aliev; Narasimha M Beeraka; Vladimir N Nikolenko; Andrey A Svistunov; Tatyana Rozhnova; Svetlana Kostyuk; Igor Cherkesov; Liliya V Gavryushova; Andrey A Chekhonatsky; Liudmila M Mikhaleva; Siva G Somasundaram; Marco F Avila-Rodriguez; Cecil E Kirkland
Journal:  J Clin Med       Date:  2020-09-12       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.